-
Je něco špatně v tomto záznamu ?
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T. Chatzikonstantinou, A. Kapetanakis, L. Scarfò, G. Karakatsoulis, D. Allsup, AA. Cabrero, M. Andres, D. Antic, M. Baile, P. Baliakas, D. Bron, A. Capasso, S. Chatzileontiadou, R. Cordoba, JG. Correa, C. Cuéllar-García, L. De Paoli, MR. De...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1997-01-01
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
- MeSH
- analýza přežití MeSH
- chronická lymfatická leukemie komplikace mortalita terapie virologie MeSH
- COVID-19 komplikace diagnóza mortalita virologie MeSH
- lidé MeSH
- mortalita MeSH
- prognóza MeSH
- rizikové faktory MeSH
- SARS-CoV-2 MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome and elucidate the impact of CLL-directed treatments on the course of COVID-19. We conducted a retrospective, international study, collectively including 941 patients with CLL and confirmed COVID-19. Data from the beginning of the pandemic until March 16, 2021, were collected from 91 centers. The risk factors of case fatality rate (CFR), disease severity, and overall survival (OS) were investigated. OS analysis was restricted to patients with severe COVID-19 (definition: hospitalization with need of oxygen or admission into an intensive care unit). CFR in patients with severe COVID-19 was 38.4%. OS was inferior for patients in all treatment categories compared to untreated (p < 0.001). Untreated patients had a lower risk of death (HR = 0.54, 95% CI:0.41-0.72). The risk of death was higher for older patients and those suffering from cardiac failure (HR = 1.03, 95% CI:1.02-1.04; HR = 1.79, 95% CI:1.04-3.07, respectively). Age, CLL-directed treatment, and cardiac failure were significant risk factors of OS. Untreated patients had a better chance of survival than those on treatment or recently treated.
Belfast City Hospital Belfast Northern Ireland
Centre for Atherothrombosis and Metabolic Disease Hull York Medical School Hull UK
Consultant Haematologist St James's Hospital Leeds LS9 7TF UK
Department of Biomedicine and Prevention Hematology University Tor Vergata Rome Italy
Department of Clinical Genetics Uppsala University Hospital Uppsala Sweden
Department of Haematology Athens Medical Center Psychikon Branch Athens Greece
Department of hematology Gelderse Vallei Ede Ede the Netherlands
Department of Hematology Haga Teaching Hospital The Hague The Netherlands
Department of Hematology Hospital del Mar Barcelona Spain
Department of Hematology Hospital General Universitario Valencia Spain
Department of Hematology Odense University Hospital Odense Denmark
Department of Hematology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Hematology Santa Chiara Hospital Trento Italy
Department of Hematology Shamir Medical Center Zerifin Israel
Department of Hematology Universitaire ziekenhuizen Leuven Herestraat 49 3000 Leuven Belgium
Department of Hematology University hospital Dubrava Zagreb Croatia
Department of Hematology Uppsala University Hospital Uppsala Sweden
Department of Internal Medicine Albert Schweitzer hospital Dordrecht the Netherlands
Department of Internal Medicine Hematology and Oncology University Hospital Brno
Department of Internal Medicine Rijnstate Hospital Arnhem the Netherlands
Department of Mathematics University of Ioannina Ioannina Greece
Department of Medicine Section of Hematology University of Verona Verona Italy
Department of Oncology and Hematology University of Milan Milan Italy
Dept Hematooncology and Bone Marrow Transplantation Medical University in Lublin Lublin Poland
Dept Internal Medicine Maastricht University Medical Center Maastricht the Netherlands
Dept of Medical Sciences Section of Hematology University of Modena and Reggio E Modena Italy
Division of Hematology AO S Croce e Carle Cuneo Italy
Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy
Experimental Hematooncology Department Medical University of Lublin Lublin Poland
Faculty of Medicine Clinical Centre of Vojvodina University of Novi Sad Novi Sad Serbia
Fundación de Investigación del Hospital General Universitario Valencia Spain
FUNDALEU Clinical research center Buenos Aires Buenos Aires Argentina
Hematologic Section Dept of Internal Medicine Hospital Union West Herning Denmark
Hematology and Clinical Immunology Unit Department of Medicine University of Padova Padova Italy
Hematology and Stem Cell Transplant Center Marche Nord Hospital Pesaro Italy
Hematology Bnai Zion Medical Center Haifa Israel
Hematology Center after Prof Yeolyan MH RA Yerevan Armenia
Hematology Clinic ASUFC Udine Italy
Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece
Hematology Department Hospital Universitario 12 de Octubre Madrid Spain
Hematology Department Hospital Universitario de La Princesa Madrid Spain
Hematology Department Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
Hematology Department Infanta Leonor University Hospital Madrid Spain
Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy
Hematology Department Portuguese Institute of Oncology Lisbon Portugal
Hematology Department Ramón y Cajal University Hospital Madrid Spain
Hematology Department St John's Cancer Center Lublin Poland
Hematology Department Unit Research Complejo Asistencial Universitario de Burgos Burgos Spain
Hematology Fondazione IRCCS Istituto Nazionale Tumori Milan Italy
Hematology Unit 1st Dept of Internal Medicine AUTH AHEPA Hospital Thessaloniki Greece
Hematology Unit and BM Transplant Center AO SS Antonio e Biagio e Cesare Arrigo Alessandria Italy
Hematology Unit AO Cosenza Cosenza Italy
Hematology Unit Azienda Unità Sanitaria Locale IRCCS Reggio Emilia Italy
Hematology Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan Milan Italy
Hematology Unit Nepal Cancer Hospital and Research Centre Lalitpur Nepal
Hematology Unit Terrassa Hospital Terrasa Spain
HematologyDepartment Colentina Clinical Hospital Bucharest Romania
Hospital Clínic of Barcelona Barcelona Spain
Hospital Clinico Universitario de Salamanca Salamanca Spain
Hospital Italiano La Plata Buenos Aires Argentina
Inst J Bordet Brussels Belgium
Institute of Applied Biosciences Centre for Research and Technology Hellas Thessaloniki Greece
IRCSS Ospedale San Raffaele Milan Italy
Pathology Service Hospital del Mar Barcelona Spain
S C Ematologia ASST Spedali Civili Brescia Brescia Italy
S C Ematologia Città della Salute e della Scienza di Torino Turin Italy
Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel
School of Medicine University of Belgrade Belgrade Serbia
Spanish Society of Haematology and hemotherapy Madrid Spain
St Anna University Hospital Ferrara Italy
Università Vita Salute San Raffaele and IRCC Ospedale San Raffaele Milan Italy
University Clinical Center of Serbia Belgrade Serbia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003119
- 003
- CZ-PrNML
- 005
- 20220127150645.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41375-021-01450-8 $2 doi
- 035 __
- $a (PubMed)34725454
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Chatzikonstantinou, Thomas $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
- 245 10
- $a COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study / $c T. Chatzikonstantinou, A. Kapetanakis, L. Scarfò, G. Karakatsoulis, D. Allsup, AA. Cabrero, M. Andres, D. Antic, M. Baile, P. Baliakas, D. Bron, A. Capasso, S. Chatzileontiadou, R. Cordoba, JG. Correa, C. Cuéllar-García, L. De Paoli, MR. De Paolis, G. Del Poeta, C. Demosthenous, M. Dimou, D. Donaldson, M. Doubek, M. Efstathopoulou, B. Eichhorst, S. El-Ashwah, A. Enrico, B. Espinet, L. Farina, A. Ferrari, M. Foglietta, H. Frederiksen, M. Fürstenau, JA. García-Marco, R. García-Serra, M. Gentile, E. Gimeno, A. Glenthøj, M. Gomes da Silva, O. Gutwein, YK. Hakobyan, Y. Herishanu, JÁ. Hernández-Rivas, T. Herold, I. Innocenti, G. Itchaki, O. Jaksic, A. Janssens, ОB. Kalashnikova, E. Kalicińska, LK. Karlsson, AP. Kater, S. Kersting, J. Labrador, D. Lad, L. Laurenti, MD. Levin, E. Lista, A. Lopez-Garcia, L. Malerba, R. Marasca, M. Marchetti, J. Marquet, M. Mattsson, FR. Mauro, I. Milosevic, F. Mirás, M. Morawska, M. Motta, T. Munir, R. Murru, CU. Niemann, RN. Rodrigues, J. Olivieri, L. Orsucci, M. Papaioannou, MA. Pavlovsky, I. Piskunova, VM. Popov, FM. Quaglia, G. Quaresmini, K. Qvist, G. Reda, GM. Rigolin, R. Ruchlemer, G. Saghumyan, A. Shrestha, M. Šimkovič, M. Špaček, P. Sportoletti, O. Stanca, N. Stavroyianni, T. Tadmor, D. Te Raa, SH. Tonino, L. Trentin, E. Van Der Spek, M. van Gelder, R. van Kampen, M. Varettoni, A. Visentin, C. Vitale, E. Wasik-Szczepanek, T. Wróbel, LY. San Segundo, M. Yassin, M. Coscia, A. Rambaldi, E. Montserrat, R. Foà, A. Cuneo, K. Stamatopoulos, P. Ghia
- 520 9_
- $a Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome and elucidate the impact of CLL-directed treatments on the course of COVID-19. We conducted a retrospective, international study, collectively including 941 patients with CLL and confirmed COVID-19. Data from the beginning of the pandemic until March 16, 2021, were collected from 91 centers. The risk factors of case fatality rate (CFR), disease severity, and overall survival (OS) were investigated. OS analysis was restricted to patients with severe COVID-19 (definition: hospitalization with need of oxygen or admission into an intensive care unit). CFR in patients with severe COVID-19 was 38.4%. OS was inferior for patients in all treatment categories compared to untreated (p < 0.001). Untreated patients had a lower risk of death (HR = 0.54, 95% CI:0.41-0.72). The risk of death was higher for older patients and those suffering from cardiac failure (HR = 1.03, 95% CI:1.02-1.04; HR = 1.79, 95% CI:1.04-3.07, respectively). Age, CLL-directed treatment, and cardiac failure were significant risk factors of OS. Untreated patients had a better chance of survival than those on treatment or recently treated.
- 650 _2
- $a COVID-19 $x komplikace $x diagnóza $x mortalita $x virologie $7 D000086382
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronická lymfatická leukemie $x komplikace $x mortalita $x terapie $x virologie $7 D015451
- 650 _2
- $a mortalita $7 D009026
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a analýza přežití $7 D016019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kapetanakis, Anargyros $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
- 700 1_
- $a Scarfò, Lydia $u Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
- 700 1_
- $a Karakatsoulis, Georgios $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece $u Department of Mathematics, University of Ioannina, Ioannina, Greece
- 700 1_
- $a Allsup, David $u Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK
- 700 1_
- $a Cabrero, Alejandro Alonso $u Spanish Society of Haematology and hemotherapy (SEHH: Sociedad Española de Hematología y hemoterapia), Madrid, Spain $u Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain
- 700 1_
- $a Andres, Martin $u Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 700 1_
- $a Antic, Darko $u University Clinical Center of Serbia, Belgrade, Serbia $u School of Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Baile, Mónica $u Hospital Clinico Universitario de Salamanca (CAUSA / IBSAL), Salamanca, Spain
- 700 1_
- $a Baliakas, Panagiotis $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden $u Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden
- 700 1_
- $a Bron, Dominique $u Inst J Bordet (ULB), Brussels, Belgium
- 700 1_
- $a Capasso, Antonella $u IRCSS Ospedale San Raffaele, Milan, Italy
- 700 1_
- $a Chatzileontiadou, Sofia $u Hematology Unit, 1st Dept of Internal Medicine, AUTH, AHEPA Hospital, Thessaloniki, Greece
- 700 1_
- $a Cordoba, Raul $u Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
- 700 1_
- $a Correa, Juan-Gonzalo $u Hospital Clínic of Barcelona, Barcelona, Spain
- 700 1_
- $a Cuéllar-García, Carolina $u Hematology Unit Terrassa Hospital, Terrasa, Spain
- 700 1_
- $a De Paoli, Lorenzo $u Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, Azienda Ospedaliero-Universitaria Maggiore della Carità Novara, Novara, Italy
- 700 1_
- $a De Paolis, Maria Rosaria $u UOC Ematologia PO Vito Fazzi Lecce, Lecce, Italy
- 700 1_
- $a Del Poeta, Giovanni $u Department of Biomedicine and Prevention Hematology, University Tor Vergata, Rome, Italy
- 700 1_
- $a Demosthenous, Christos $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
- 700 1_
- $a Dimou, Maria $u 1st Internal Medicine Department, Propaedeutic, Hematology Clinical Trial Unit, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Donaldson, David $u Belfast City Hospital, Belfast, Northern Ireland
- 700 1_
- $a Doubek, Michael $u Department of Internal Medicine - Hematology and Oncology, University Hospital, Brno; Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Efstathopoulou, Maria $u Department of Haematology Athens Medical Center-Psychikon Branch, Athens, Greece
- 700 1_
- $a Eichhorst, Barbara $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital Cologne, University of Cologne, Cologne, Germany
- 700 1_
- $a El-Ashwah, Shaimaa $u Clinical Hematology Unit, Oncology Center, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt
- 700 1_
- $a Enrico, Alicia $u Hospital Italiano La Plata, Buenos Aires, Argentina
- 700 1_
- $a Espinet, Blanca $u Pathology Service, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Farina, Lucia $u Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
- 700 1_
- $a Ferrari, Angela $u Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
- 700 1_
- $a Foglietta, Myriam $u Division of Hematology, AO S. Croce e Carle, Cuneo, Italy
- 700 1_
- $a Frederiksen, Henrik $u Department of Hematology, Odense University Hospital, Odense, Denmark
- 700 1_
- $a Fürstenau, Moritz $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital Cologne, University of Cologne, Cologne, Germany
- 700 1_
- $a García-Marco, José A $u Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
- 700 1_
- $a García-Serra, Rocío $u Department of Hematology, Hospital General Universitario, Valencia, Spain $u Fundación de Investigación del Hospital General Universitario, Valencia, Spain
- 700 1_
- $a Gentile, Massimo $u Hematology Unit AO Cosenza, Cosenza, Italy
- 700 1_
- $a Gimeno, Eva $u Department of Hematology, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Gomes da Silva, Maria $u Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Gutwein, Odit $u Department of Hematology, Shamir Medical Center, Zerifin, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- 700 1_
- $a Hakobyan, Yervand K $u Hematology Center after Prof. Yeolyan MH RA, Yerevan, Armenia
- 700 1_
- $a Herishanu, Yair $u Department of Hematology, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
- 700 1_
- $a Hernández-Rivas, José Ángel $u Hematology Department Infanta Leonor University Hospital, Madrid, Spain
- 700 1_
- $a Herold, Tobias $u Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
- 700 1_
- $a Innocenti, Idanna $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- 700 1_
- $a Itchaki, Gilad $u Rabin Medical Center, Petah Tikva, and the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- 700 1_
- $a Jaksic, Ozren $u Department of Hematology, University hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Janssens, Ann $u Department of Hematology, Universitaire ziekenhuizen Leuven, Herestraat 49, 3000, Leuven, Belgium
- 700 1_
- $a Kalashnikova, Оlga B $u Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russia
- 700 1_
- $a Kalicińska, Elżbieta $u Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University, Pasteura Street 4, 50-367, Wroclaw, Poland
- 700 1_
- $a Karlsson, Linda Katharina $u Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Kater, Arnon P $u Dept of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Kersting, Sabina $u Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands
- 700 1_
- $a Labrador, Jorge $u Hematology Department, Unit Research, Complejo Asistencial Universitario de Burgos, Burgos, Spain
- 700 1_
- $a Lad, Deepesh $u Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
- 700 1_
- $a Laurenti, Luca $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy $u Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Levin, Mark-David $u Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands
- 700 1_
- $a Lista, Enrico $u Department of Hematology, Santa Chiara Hospital, Trento, Italy
- 700 1_
- $a Lopez-Garcia, Alberto $u Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
- 700 1_
- $a Malerba, Lara $u Hematology and Stem Cell Transplant Center Marche Nord Hospital, Pesaro, Italy
- 700 1_
- $a Marasca, Roberto $u Dept of Medical Sciences, Section of Hematology, University of Modena and Reggio E., Modena, Italy
- 700 1_
- $a Marchetti, Monia $u Hematology Unit and BM Transplant Center, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Marquet, Juan $u Hematology Department, Ramón y Cajal University Hospital, Madrid, Spain
- 700 1_
- $a Mattsson, Mattias $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden $u Department of Hematology, Uppsala University Hospital, Uppsala, Sweden
- 700 1_
- $a Mauro, Francesca R $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Milosevic, Ivana $u Faculty of Medicine, Clinical Centre of Vojvodina, University of Novi Sad, Novi Sad, Serbia
- 700 1_
- $a Mirás, Fatima $u Hematology Department Hospital Universitario 12 de Octubre, Madrid, Spain
- 700 1_
- $a Morawska, Marta $u Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland $u Hematology Department, St. John's Cancer Center, Lublin, Poland
- 700 1_
- $a Motta, Marina $u S.C. Ematologia ASST Spedali Civili Brescia, Brescia, Italy
- 700 1_
- $a Munir, Talha $u Consultant Haematologist, St James's Hospital, Leeds, LS9 7TF, UK
- 700 1_
- $a Murru, Roberta $u Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy
- 700 1_
- $a Niemann, Carsten U $u Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Rodrigues, Raquel Nunes $u Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Olivieri, Jacopo $u Hematology Clinic, ASUFC, Udine, Italy
- 700 1_
- $a Orsucci, Lorella $u S.C. Ematologia, Città della Salute e della Scienza di Torino, Turin, Italy
- 700 1_
- $a Papaioannou, Maria $u Hematology Unit, 1st Dept of Internal Medicine, AUTH, AHEPA Hospital, Thessaloniki, Greece
- 700 1_
- $a Pavlovsky, Miguel Arturo $u FUNDALEU, Clinical research center Buenos Aires, Buenos Aires, Argentina
- 700 1_
- $a Piskunova, Inga $u Consultative Hematology Department with a Day Hospital for Intensive High-Dose Chemotherapy, National Research Center for Hematology, Moscow, Russia
- 700 1_
- $a Popov, Viola Maria $u HematologyDepartment, Colentina Clinical Hospital, Bucharest, Romania
- 700 1_
- $a Quaglia, Francesca Maria $u Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
- 700 1_
- $a Quaresmini, Giulia $u Department of Oncology and Hematology Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Bergamo, Italy
- 700 1_
- $a Qvist, Kristian $u Hematologic Section, Dept. of Internal Medicine, Hospital Union West, Herning, Denmark
- 700 1_
- $a Reda, Gianluigi $u Hematology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
- 700 1_
- $a Rigolin, Gian Matteo $u St. Anna University Hospital, Ferrara, Italy
- 700 1_
- $a Ruchlemer, Rosa $u Department of Hematology, Shaare-Zedek Medical Center, affiliated with the Hebrew University Medical School, Jerusalem, Israel
- 700 1_
- $a Saghumyan, Gevorg $u Hematology Center after Prof. Yeolyan MH RA, Yerevan, Armenia
- 700 1_
- $a Shrestha, Amit $u Hematology Unit, Nepal Cancer Hospital & Research Centre, Lalitpur, Nepal
- 700 1_
- $a Šimkovič, Martin $u 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic
- 700 1_
- $a Špaček, Martin $u 1st Department of Medicine - Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Sportoletti, Paolo $u Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncological Research, University of Perugia, Perugia, Italy
- 700 1_
- $a Stanca, Oana $u "Carol Davila" University of Medicine and Pharmacy - Hematology Department from Coltea Clinical Hospital, Bucharest, Romania
- 700 1_
- $a Stavroyianni, Niki $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
- 700 1_
- $a Tadmor, Tamar $u Hematology, Bnai-Zion Medical Center, Haifa, Israel
- 700 1_
- $a Te Raa, Doreen $u Department of hematology, Gelderse Vallei Ede, Ede, the Netherlands
- 700 1_
- $a Tonino, Sanne H $u Dept of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Trentin, Livio $u Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padova, Italy
- 700 1_
- $a Van Der Spek, Ellen $u Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands
- 700 1_
- $a van Gelder, Michel $u Dept Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
- 700 1_
- $a van Kampen, Roel $u Zuyderland Medical Center, Sittard, the Netherlands
- 700 1_
- $a Varettoni, Marzia $u Division of Hematology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- 700 1_
- $a Visentin, Andrea $u Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padova, Italy
- 700 1_
- $a Vitale, Candida $u Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
- 700 1_
- $a Wasik-Szczepanek, Ewa $u Dept. Hematooncology and Bone Marrow Transplantation Medical University in Lublin, Lublin, Poland
- 700 1_
- $a Wróbel, Tomasz $u Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University, Pasteura Street 4, 50-367, Wroclaw, Poland
- 700 1_
- $a San Segundo, Lucrecia Yáñez $u Hematology Department, University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain
- 700 1_
- $a Yassin, Mohamed $u Hematology Section, Department of Medical Oncology, National Center for Cancer Care and Research, Doha, Qatar
- 700 1_
- $a Coscia, Marta $u Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
- 700 1_
- $a Rambaldi, Alessandro $u Department of Oncology and Hematology Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Bergamo, Italy $u Department of Oncology and Hematology, University of Milan, Milan, Italy
- 700 1_
- $a Montserrat, Emili $u Hospital Clínic of Barcelona, Barcelona, Spain
- 700 1_
- $a Foà, Robin $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Cuneo, Antonio $u St. Anna University Hospital, Ferrara, Italy
- 700 1_
- $a Stamatopoulos, Kostas $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. kostas.stamatopoulos@certh.gr
- 700 1_
- $a Ghia, Paolo $u Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy. ghia.paolo@hsr.it
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 35, č. 12 (2021), s. 3444-3454
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34725454 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150641 $b ABA008
- 999 __
- $a ok $b bmc $g 1750783 $s 1154268
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 35 $c 12 $d 3444-3454 $e 20211101 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- LZP __
- $a Pubmed-20220113
